Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease

被引:117
作者
Barakzoy, Ahmad S. [1 ]
Moss, Alvin H. [1 ]
机构
[1] W Virginia Univ, Sch Med, Ctr Hlth Eth & Law, Dept Med,Sect Nephrol, Morgantown, WV 26506 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 11期
关键词
D O I
10.1681/ASN.2006050477
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Pain is the one of the most common symptoms experienced by patients with ESRD; it impairs their quality of life and is undertreated. Most pain clinicians believe that the pain management approach of the World Health Organization (WHO) three-step analgesic ladder is applicable to the treatment of patients with ESRD, but this approach has not been validated for them. A cohort of 45 hemodialysis patients were assessed for type and severity of pain using the Short-Form McGill Pain Questionnaire and then treated during a 4-wk period according to the WHO analgesic ladder. Mean age was 65 +/- 12.5 yr, and 22 (49%) patients had diabetic nephropathy as the cause of ESRD. Initial pain was rated severe by 34 (76%) patients. There was no difference in initial pain rating by gender, age, race, or type of pain. Forty percent of patients reported nociceptive pain, 31% neuropathic, and 29% both. Adequate analgesia was achieved in 43 (96%) of 45 patients. The mean pain score decreased from 7.8 +/- 1.2 to 1.6 +/- 1.3 (P < 0.001). Patients who were 65 yr and older had higher posttreatment scores than those who were younger than 65 (2.1 +/- 1.4 versus 0.94 +/- 0.93; P = 0.002) and more medication adverse effects. It is concluded that the use of the WHO three-step analgesic ladder leads to effective pain relief in hemodialysis patients. Older patients will need more careful pain management to achieve the same results as younger patients. Further studies are needed to confirm these results in a larger, more diverse dialysis population.
引用
收藏
页码:3198 / 3203
页数:6
相关论文
共 26 条
[1]  
*AM MED ASS, 1999, EPEC PROJ ED PHYS EN
[2]  
American Pain Society, 2003, PRINC AN US TREATM A
[3]  
[Anonymous], OXFORD TXB PALLIATIV
[4]  
[Anonymous], 1990, CANC PAIN REL PALL C
[5]   Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription [J].
Bailie, GR ;
Mason, NA ;
Bragg-Gresham, JL ;
Gillespie, BW ;
Young, EW .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2419-2425
[6]   The family perspective of ESRD deaths [J].
Cohen, LM ;
Germain, MJ ;
Woods, AL ;
Mirot, A ;
Burleson, JA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :154-161
[7]   Controversies in pharmacotherapy of pain management [J].
Davis, MP ;
Walsh, D ;
Lagman, R ;
LeGrand, SB .
LANCET ONCOLOGY, 2005, 6 (09) :696-704
[8]   The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients [J].
Davison, SN ;
Jhangri, GS .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 30 (05) :465-473
[9]   Chronic pain in end-stage renal disease [J].
Davison, SN .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (03) :326-334
[10]   Pain in hemodialysis patients: Prevalence, cause, severity, and management [J].
Davison, SN .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1239-1247